Medivation | Evaluate

January 11, 2017

JP Morgan day two roundup – all talk, very little action

October 17, 2016

M&A gives signs of reverting to the mean

October 07, 2016

Lively M&A scene keeps biotech shares buoyant in Q3

September 29, 2016

Esmo preview – Novel checkpoints add to the Parp showdown

September 26, 2016

No great disturbance for pharma’s biggest force

September 12, 2016

Raptor faces up to its new reality

September 09, 2016

Snippet roundup: Gilead’s Parp interest, Futura and Retrophin get data boost

September 07, 2016

How Gilead could go back to basics

August 26, 2016

Esmo preview – A Merck versus Bristol showdown

August 24, 2016

Few M&A teams venture beyond domestic borders

August 24, 2016

Committed seller could give Pfizer an antibiotic bargain

Load More